Lilly Advances IL-23, Gastroenterology Ambitions With Mirikizumab In Crohn's Disease

 
• By Mandy Jackson
Crohn's disease (gastrointestinal disease) diagnosis medical concept on tablet screen with stethoscope. - Image
Mirikizumab could be the second IL-23 inhibitor for IBD indications. • Source: Shutterstock

More from Clinical Trials

More from R&D